Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study.

Alejandra Monserrat Rodríguez-Ramírez María Teresa Alcántara-Garcés Sergio Hernández-Jiménez Ana Cristina García-UlloaDenise Arcila-MartínezHéctor Velázquez-JuradoRodrigo Eduardo Arizmendi-Rodrígueznull null

Published in: Neuropsychiatric disease and treatment (2023)

Patients with AXD had the worst glycemic control at 3 and 12 months of follow-up. HbA1c differences in patients with AXD compared with non-AXD subjects increases over time in association with anxiety symptoms.

Keyphrases

glycemic control
type diabetes
end stage renal disease
sleep quality
ejection fraction
chronic kidney disease
newly diagnosed
weight loss
insulin resistance
prognostic factors
metabolic syndrome
adipose tissue
physical activity
skeletal muscle
patient reported outcomes
depressive symptoms